Urology Times 50 Innovations Series: Radiation therapy for prostate cancer

Video

"I would say our greatest advance of the past 30 years is our clinical trials infrastructure, because we can now use our therapies with intelligence," says Anthony Zietman, MD.

Urology Times® is celebrating its 50th anniversary in 2022. To mark the occasion, we are high-lighting 50 of the top innovations and developments that have transformed the field of urology over the past 50 years. In this installment, Anthony Zietman, MD, discusses the development of radia-tion therapy for prostate cancer. Zietman is interim chief of Radiation Oncology at Massachusetts General Hospital in Boston and has recently retired as Editor-in-Chief of the International Journal of Radiation Oncology Biology Physics (The “Red Journal”).

Related Videos
blur image background of corridor in hospital or clinic image | Image Credit @ whyframeshot - stock.adobe.com
Dr. Mehmet Asim Bilen in an interview with Urology Times
blurred clinic hallway
Dr. Adam Weiner in an interview with Urology Times
Dr. Sagar Patel in an interview with Urology Times
Related Content
© 2024 MJH Life Sciences

All rights reserved.